Effects of IMT on Respiratory, Diaphragmatic and Balance Functions, Exercise Capacity and QOL in People After Stroke
Launched by HONG KONG METROPOLITAN UNIVERSITY · Jun 1, 2024
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a specific type of breathing exercise called Inspiratory Muscle Training (IMT) can help improve various functions in people who have had a stroke. The researchers want to see if doing these breathing exercises for four weeks can enhance breathing, balance, exercise ability, and overall quality of life for stroke survivors.
To participate in this study, individuals need to be between 40 and 80 years old and have experienced a stroke within the last 1 to 12 months. They should be able to breathe on their own, understand instructions, and walk at least 10 meters, either with or without help. However, people with certain health issues, like severe heart problems or respiratory illnesses, will not be eligible to join. Throughout the trial, participants will engage in supervised exercises and receive support to help monitor their progress and well-being. This research could provide valuable insights into helping stroke survivors regain strength and improve their daily lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • aged between 40 and 80 years;
- • breathing spontaneously;
- • clinically diagnosed with ischemic and/or haemorrhagic stroke;
- • stroke duration from onset between 1 and 12 months;
- • no history of thoracic or abdominal surgery within the last 6 months;
- • able to understand and follow verbal instructions;
- • no facial palsy, or mild facial palsy without limitation of labial occlusion;
- • capable of maintaining a resting sitting posture without feet support for at least 30 seconds;
- • no cognitive impairment, as indicated by a Montreal Cognitive Assessment (MoCA) score of ≥ 26;
- • able to independently walk at least 10 meters with or without an assistive device.
- Exclusion criteria:
- • acute myocardial infarction or acute heart failure;
- • acute pain in any part of the body;
- • with respiratory illness or positive clinical signs of impaired respiratory function, such as shortness of breath, hypoxemia, chronic cough, or sputum retention;
- • with chronic cardiovascular dysfunction;
- • Trunk Impairment Scale (TIS) score ≥ 20;
- • presence of a nasal feeding tube, tracheal tube, or any condition that prevents the measurement or implementation of the study procedure.
About Hong Kong Metropolitan University
Hong Kong Metropolitan University (HKMU) is a leading institution committed to advancing research and education in various fields, including health sciences. As a clinical trial sponsor, HKMU leverages its robust academic resources and expertise to facilitate innovative research initiatives aimed at improving patient care and health outcomes. The university fosters collaboration among multidisciplinary teams, ensuring adherence to rigorous ethical standards and regulatory compliance throughout the research process. HKMU's commitment to excellence in clinical research not only enhances its academic reputation but also contributes significantly to the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Fang LIU
Principal Investigator
Hong Kong Metropolitan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported